February 24th 2021
The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction.
February 22nd 2021
Application to the FDA is based on results from a placebo-controlled trial showing a 15% decrease in body weight among those who are obese or overweight.
February 16th 2021
February 16th 2021
February 10th 2021
One of the new treatments available is a CAR-T cell therapy to treat relapsed or refractory large B-cell lymphoma.